Begoña Lavin

Begoña Lavin

Auto-generated profile, based on publicly available information

Begoña Lavin

Department of Biochemistry and Molecular Biology, School of Chemistry, Complutense University of Madrid, Madrid, Spain

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2018 in Basic Research in Cardiology
Verified
Journal Article
Open access
PDF file
DCDaniel Curley
Daniel Curley
BPBegoña Lavin Plaza
Begoña Lavin Plaza
ASAjay M. Shah
Ajay M. Shah
RBRene Botnar
Rene Botnar
Myocardial infarction and subsequent heart failure is a major health burden associated with significant mortality and morbidity in western societies. The ability of cardiac tissue to recover after myocardial infarction is affected by numerous complex cellular and molecular pathways. Unbalance or failure of these pathways can lead to adverse remodelling of the heart and poor prognosis. Current clinical cardiac imaging modalities assess anatomy, perfusion, function, and viability of the myocardium, yet do not offer any insight into the specific molecular pathways involved in the repair process. Novel imaging techniques allow visualisation of these molecular processes and may have significant diagnostic and prognostic values, which could aid clinical management. Single photon-emission tomography, positron-emission tomography, and magnetic resonance imaging are used to visualise various aspects of these molecular processes. Imaging probes are usually attached to radioisotopes or paramagnetic nanoparticles to specifically target biological processes such as: apoptosis, necrosis, inflammation, angiogenesis, and scar formation. Although the results from preclinical studies are promising, translating this work to a clinical environment in a valuable and cost-effective way is extremely challenging. Extensive evaluation evidence of diagnostic and prognostic values in multi-centre clinical trials is still required.

19 November 2021 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
PDF file
CVCarlos Velasco
Carlos Velasco
GCGastão Cruz
Gastão Cruz
BLBegoña Lavin
Begoña Lavin
AHAlina Hua
Alina Hua
AFAnastasia Fotaki
Anastasia Fotaki
CPClaudia Prieto
Claudia Prieto
Purpose: To develop a simultaneous T1, T2, and T1ρ cardiac magnetic resonance fingerprinting (MRF) approach to enable comprehensive contrast agent–free myocardial tissue characterization in a single breath‐hold scan.Methods: A 2D gradient‐echo electrocardiogram‐triggered cardiac MRF sequence with low flip angles, varying magnetization preparation, and spiral trajectory was acquired at 1.5 T to encode T1, T2, and T1⍴ simultaneously. The MRF images were reconstructed using low‐rank inversion, regularized with a multicontrast patch‐based higher‐order reconstruction. Parametric maps were generated and matched in the singular value domain to extended phase graph–based dictionaries. The proposed approach was tested in phantoms and 10 healthy subjects and compared against conventional methods in terms of coefficients of determination and best fits for the phantom study, and in terms of Bland‐Altman agreement, average values and coefficient of variation of T1, T2, and T1⍴ for the healthy subjects study.Results: The T1, T2, and T1⍴ MRF values showed excellent correlation with conventional spin‐echo and clinical mapping methods in phantom studies (r2 > 0.97). Measured MRF values in myocardial tissue (mean ± SD) were 1133 ± 33 ms, 38.8 ± 3.5 ms, and 52.0 ± 4.0 ms for T1, T2 and T1⍴, respectively, against 1053 ± 47 ms, 50.4 ± 3.9 ms, and 55.9 ± 3.3 ms for T1 modified Look‐Locker inversion imaging, T2 gradient and spin echo, and T1⍴ turbo field echo, respectively.Conclusion: A cardiac MRF approach for simultaneous quantification of myocardial T1, T2, and T1ρ in a single breath‐hold MR scan of about 16 seconds has been proposed. The approach has been investigated in phantoms and healthy subjects showing good agreement with reference spin echo measurements and conventional clinical maps.

18 November 2021 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
PDF file
CVCarlos Velasco
Carlos Velasco
GCGastão Cruz
Gastão Cruz
OJOlivier Jaubert
Olivier Jaubert
BLBegoña Lavin
Begoña Lavin
RBRene Botnar
Rene Botnar
CPClaudia Prieto
Claudia Prieto
Purpose: To develop a novel simultaneous co‐registered T1, T2, , T1ρ, and fat fraction abdominal MR fingerprinting (MRF) approach for fully comprehensive liver‐tissue characterization in a single breath‐hold scan.Methods: A gradient‐echo liver MRF sequence with low fixed flip angle, multi‐echo radial readout, and varying magnetization preparation pulses for multiparametric encoding is performed at 1.5 T. The and fat fraction are estimated from a graph/cut water/fat separation method using a six‐peak fat model. Water/fat singular images obtained are then matched to an MRF dictionary, estimating water‐specific T1, T2, and T1ρ. The proposed approach was tested in phantoms and 10 healthy subjects and compared against conventional sequences.Results: For the phantom studies, linear fits show excellent coefficients of determination (r2 > 0.9) for every parametric map. For in vivo studies, the average values measured within regions of interest drawn on liver, spleen, muscle, and fat are statistically different from the reference scans (p < 0.05) for T1, T2, and T1⍴ but not for and fat fraction, whereas correlation between MRF and reference scans is excellent for each parameter (r2 > 0.92 for every parameter).Conclusion: The proposed multi‐echo inversion‐recovery, T2, and T1⍴ prepared liver MRF sequence presented in this work allows for quantitative T1, T2, , T1⍴, and fat fraction liver‐tissue characterization in a single breath‐hold scan of 18 seconds. The approach showed good agreement and correlation with respect to reference clinical maps.

1 September 2020 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Open access
PDF file
BPBegoña Lavin Plaza
Begoña Lavin Plaza
APAlkystis Phinikaridou
Alkystis Phinikaridou
MAMarcelo E. Andia
Marcelo E. Andia
MPMyles Potter
Myles Potter
SLSilvia Lorrio
Silvia Lorrio
RBRene M. Botnar
Rene M. Botnar
Objective: Evidence from preclinical and clinical studies has demonstrated that myocardial infarction promotes atherosclerosis progression. The impact of focal vascular inflammation on the progress...

1 August 2018 in Atherosclerosis
Verified
Journal Article
Open access
BLBegoña Lavin
Begoña Lavin
APAndrea Protti
Andrea Protti
SLSilvia Lorrio
Silvia Lorrio
XDXuebin Dong
Xuebin Dong
APAlkystis Phinikaridou
Alkystis Phinikaridou
ASAjay Shah
Ajay Shah
Acute ischemia is associated with myocardial endothelial damage and microvessel formation, resulting in leakage of plasma albumin into the myocardial extravascular space. In this study, we tested whether an albumin-binding intravascular contrast agent (gadofosveset) allows for improved quantification of myocardial permeability compared to the conventional extracellular contrast agent Gd-DTPA using late gadolinium enhancement (LGE) and T1 mapping in vivo. MI was induced in C57BL/6 mice (n = 6) and cardiac magnetic resonance imaging (CMR) was performed at 3, 10 and 21 days post-MI using Gd-DTPA and 24 h later using gadofosveset. Functional, LGE and T1 mapping protocols were performed 45 min post-injection of the contrast agent. LGE images showed that both contrast agents provided similar measurements of infarct area at all time points following MI. Importantly, the myocardial R1 measurements after administration of gadofosveset were higher in the acute phase-day 3 (R1 [s-1] = 6.29 ± 0.29) compared to the maturation phase-days 10 and 21 (R1 [s-1] = 4.76 ± 0.30 and 4.48 ± 0.14), suggesting that the uptake of this agent could be used to stage myocardial remodeling. No differences in myocardial R1 were observed after administration of Gd-DTPA at different time points post-MI (R1 [s-1] = 3d: 3.77 ± 0.37; 10d: 2.74 ± 0.06; 21d: 3.35 ± 0.26). The MRI results were validated by ex vivo histology that showed albumin leakage in the myocardium in the acute phase and microvessel formation at later stages. We demonstrate the merits of an albumin-binding contrast agent for monitoring changes in myocardial permeability between acute ischemia and chronic post-MI myocardial remodeling.

11 April 2023 in NMR in Biomedicine
Verified
Journal Article
Open access
BLBegoña Lavin
Begoña Lavin
TEThomas R. Eykyn
Thomas R. Eykyn
APAlkystis Phinikaridou
Alkystis Phinikaridou
AXAline Xavier
Aline Xavier
SKShravan Kumar
Shravan Kumar
MAMarcelo E. Andia
Marcelo E. Andia
Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease worldwide. Liver biopsy remains the gold standard for diagnosis and staging of disease. There is a clinical need for noninvasive diagnostic tools for risk stratification, follow‐up, and monitoring treatment response that are currently lacking, as well as preclinical models that recapitulate the etiology of the human condition. We have characterized the progression of NAFLD in eNOS−/− mice fed a high fat diet (HFD) using noninvasive Dixon‐based magnetic resonance imaging and single voxel STEAM spectroscopy‐based protocols to measure liver fat fraction at 3 T. After 8 weeks of diet intervention, eNOS−/− mice exhibited significant accumulation of intra‐abdominal and liver fat compared with control mice. Liver fat fraction measured by 1H‐MRS in vivo showed a good correlation with the NAFLD activity score measured by histology. Treatment of HFD‐fed NOS3−/− mice with metformin showed significantly reduced liver fat fraction and altered hepatic lipidomic profile compared with untreated mice. Our results show the potential of in vivo liver MRI and 1H‐MRS to noninvasively diagnose and stage the progression of NAFLD and to monitor treatment response in an eNOS−/− murine model that represents the classic NAFLD phenotype associated with metabolic syndrome.